CR7720A - Acetil 2-hidroxi-1,3- diaminoalcanos - Google Patents

Acetil 2-hidroxi-1,3- diaminoalcanos

Info

Publication number
CR7720A
CR7720A CR7720A CR7720A CR7720A CR 7720 A CR7720 A CR 7720A CR 7720 A CR7720 A CR 7720A CR 7720 A CR7720 A CR 7720A CR 7720 A CR7720 A CR 7720A
Authority
CR
Costa Rica
Prior art keywords
diaminoalcane
hydroxi
oil
compounds
disclosed
Prior art date
Application number
CR7720A
Other languages
English (en)
Inventor
Maillard Michel
T Baldwin Eric
P Beck James
Hughes Robert
Varghese John
R Pulley Shon
Tenbrink Ruth
Original Assignee
Elan Pharm Inc
Upjohn Co
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Elan Pharm Inc, Upjohn Co filed Critical Elan Pharm Inc
Publication of CR7720A publication Critical patent/CR7720A/es

Links

Landscapes

  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
  • Peptides Or Proteins (AREA)

Abstract

Se divulgan compuestos de la Formula I. Donde las variables Z,X, R15, R2, R3, Rc son definidas aqui. Los compuestos divulgados aqui son inhibidores de la enzima beta secretasa y por lo tanto, son utiles para el tratamiento de la enfermedad del Alzheimer y otras enfermedades caracterizadas por la deposicion del peptido A beta en un mamifero.
CR7720A 2002-09-10 2005-03-09 Acetil 2-hidroxi-1,3- diaminoalcanos CR7720A (es)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US40945302P 2002-09-10 2002-09-10

Publications (1)

Publication Number Publication Date
CR7720A true CR7720A (es) 2005-07-14

Family

ID=35353421

Family Applications (1)

Application Number Title Priority Date Filing Date
CR7720A CR7720A (es) 2002-09-10 2005-03-09 Acetil 2-hidroxi-1,3- diaminoalcanos

Country Status (5)

Country Link
CN (1) CN100384824C (es)
AP (1) AP2005003247A0 (es)
CR (1) CR7720A (es)
TN (1) TNSN05067A1 (es)
ZA (1) ZA200501991B (es)

Families Citing this family (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE102010030538A1 (de) * 2010-06-25 2011-12-29 Bayer Schering Pharma Aktiengesellschaft 6,7-Dihydro-5H-benzo[7]annulen-Derivate, Verfahren zu ihrer Herstellung, pharmazeutische Präparate die diese enthalten, sowie deren Verwendung zur Herstellung von Arzneimitteln
DE102011087987A1 (de) * 2011-12-08 2013-06-13 Bayer Intellectual Property Gmbh 6,7-Dihydro-5H-benzo[7]annulen-Derivate, Verfahren zu ihrer Herstellung, pharmazeutische Präparate die diese enthalten, sowie deren Verwendung zur Herstellung von Arzneimitteln
CN109790079B (zh) * 2016-07-29 2022-06-03 香港科技大学 有机锌试剂与杂环(拟)卤化物的C(sp3)-C(sp2)交叉偶联反应
MX2019000982A (es) 2016-07-29 2019-07-04 Sunovion Pharmaceuticals Inc Compuestos y composiciones y usos de los mismos.
JP7191085B2 (ja) 2017-08-02 2022-12-16 サノビオン ファーマシューティカルズ インク イソクロマン化合物およびその使用
CN113189089B (zh) * 2021-03-19 2022-05-17 四川轻化工大学 一种臭氧检测试剂及其制备装置和制备方法

Family Cites Families (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5482947A (en) * 1990-11-19 1996-01-09 Talley; John J. Retroviral protease inhibitors
EP0958293B1 (en) * 1997-02-04 2005-01-19 The Regents Of The University Of California Nanomolar, non-peptide inhibitors of cathepsin d

Also Published As

Publication number Publication date
CN100384824C (zh) 2008-04-30
TNSN05067A1 (en) 2007-05-14
CN1694870A (zh) 2005-11-09
AP2005003247A0 (en) 2005-03-31
ZA200501991B (en) 2006-01-25

Similar Documents

Publication Publication Date Title
ECSP055696A (es) Acetil 2-hidroxi-1, 3-diaminoalcanos
UY28101A1 (es) Ureas substituidas y carbamatos útiles para el tratamiento de la enfermedad de alzheimer
DOP2004000888A (es) 2-hidroxi-3-diaminoalcanos de benzamida (benzamide 2-hydroxy-3-diaminoalkanes
UY28279A1 (es) Fenacilo 2 -hidroxi - 3 - diaminoalcanos
UY27918A1 (es) Derivados de benzodioxol
UY27774A1 (es) Inhibidores de metaloproteinas de triaril-oxi-aril-espiropirimidina-2,4,6-triona
UY26480A1 (es) Inhibidores de n - (5 - ( 5 - alquil - 2 - oxazolil) metil ) tio) - 2 - tiazolil) - carboxamida de cinasas dependientes de ciclina
ECSP044992A (es) Inhibidores de la alquín-aril fosfodiesterasa-4
ECSP055719A (es) Compuestos de tiazol para el tratamiento de trastornos neurodegenerativos
NZ516599A (en) 2-arylimino-2,3-dihydrothiazoles, and their use thereof as somatostatin receptor ligands
EA200701504A1 (ru) Индолы, пригодные для лечения воспалений
UY28450A1 (es) Compuestos heteroarilo de 6 miembros para el tratamiento de trastornos neurodegenerativos.
UY27338A1 (es) Nuevos derivados de ácido sulfónico
UY26481A1 (es) Inhibidores de n - (5 - ( ( (5 - alquil - 2 - oxazolil) metil) tio) - 2 - tiazolil) - carboxamida de cinasas dependientes de ciclina.
UY27842A1 (es) Fluorobenzamidas
ATE323084T1 (de) Für die behandlung von alzheimer krankheit geeignete makrocyclen
UY28484A1 (es) Compuestos para el tratamiento de trastornos neurodegenerativos
BR0213138A (pt) Métodos de tratar ou prevenir mal de alzheimer e uma doença distinguida por depósito de beta-amilóide no cérebro, de tratar um paciente que tenha, ou de prevenir um paciente de contrair uma doença ou condição, de produzir um complexo de beta-secretase e de inibir a produção de placa beta-amilóide em um animal, composição e uso de um composto
WO2005095326A8 (en) 2-amino- and 2-thio-substituted 1,3-diaminopropanes
DE602004023185D1 (de) Phenylsulfonderivate und deren verwendung bei der behandlung von zns-erkrankungen
BR0306855A (pt) Método para o tratamento de distúrbios cognitivos
NO20062629L (no) Oksazolderivater av tetrackliner
UY27451A1 (es) 2,5-diamidoindoles sustituidos y su utilización
UY28458A1 (es) Compuestos de oxazol para el tratamiento de trastornos neurodegenerativos
NO970340D0 (no) Organiske forbindelser

Legal Events

Date Code Title Description
FA Abandonment or withdrawal (granting procedure)